Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Intensity Therapeutics, Inc. - Common Stock
(NQ:
INTS
)
7.283
-0.137 (-1.85%)
Streaming Delayed Price
Updated: 10:30 AM EDT, Mar 13, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Intensity Therapeutics, Inc. - Common Stock
< Previous
1
2
3
Next >
Let's have a look at the top gainers and losers one hour before the close of the markets of today's session.
↗
February 13, 2026
Via
Chartmill
Let's take a look at the stocks that are in motion in today's session.
↗
February 13, 2026
Via
Chartmill
Traders are paying attention to the gapping stocks in Friday's session.
↗
February 13, 2026
Via
Chartmill
Why Did INTS Stock Plummet 30% Pre-Market Today?
↗
February 13, 2026
Intensity Therapeutics announced a 1-for-25 reverse stock split, consolidating every 25 existing shares into a single new share.
Via
Stocktwits
12 Health Care Stocks Moving In Wednesday's After-Market Session
↗
November 12, 2025
Via
Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
↗
October 31, 2025
Via
Benzinga
Which stocks are experiencing notable movement on Friday?
↗
October 31, 2025
Intrigued by the market activity one hour before the close of the markets on Friday? Uncover the key winners and losers of today's session in our insightful analysis.
Via
Chartmill
These stocks are making the most noise in today's session.
↗
October 31, 2025
Curious about the most active stocks in today's session? Get a glimpse into the stocks that are generating the highest trading volume and capturing market attention.
Via
Chartmill
These stocks have an unusual volume in today's session
↗
October 31, 2025
In today's session, these stocks are experiencing unusual volume.
Via
Chartmill
Dow Falls Over 100 Points; Amazon Posts Upbeat Q3 Results
↗
October 31, 2025
Via
Benzinga
Topics
Stocks
Let's have a look at the top gainers and losers in the middle of the day of today's session.
↗
October 31, 2025
Curious to know what's happening on the US markets in the middle of the day on Friday? Join us as we explore the top gainers and losers in today's session.
Via
Chartmill
12 Health Care Stocks Moving In Friday's Intraday Session
↗
October 31, 2025
Via
Benzinga
Let's uncover which stocks are experiencing notable gaps during today's session.
↗
October 31, 2025
Let's have a look at the gap up and gap down stocks in today's session.
Via
Chartmill
Discover the top movers in Friday's pre-market session.
↗
October 31, 2025
Before the US market kicks off on Friday, let's examine the pre-market session and unveil the notable performers among the top gainers and losers.
Via
Chartmill
Why Amazon Shares Are Trading Higher By Over 12%; Here Are 20 Stocks Moving Premarket
↗
October 31, 2025
Via
Benzinga
Intensity Therapeutics Stock Cools After-Hours Following 395% Surge: What You Should Know
↗
October 31, 2025
Intensity Therapeutics shares plunged 31.9% after-hours following the publication of Phase 1/2 trial results for its cancer therapy INT230-6.
Via
Benzinga
Top movers in Thursday's after hours session
↗
October 30, 2025
The regular session of the US market on Thursday is now over, but let's get a preview of the after-hours session and explore the top gainers and losers driving the post-market movements.
Via
Chartmill
12 Health Care Stocks Moving In Thursday's After-Market Session
↗
October 30, 2025
Via
Benzinga
Check out the stocks that are attracting the most attention and driving market activity.
↗
October 30, 2025
Let's dive into the action on the US markets on Thursday. Here are the most active stocks that are driving the market today.
Via
Chartmill
12 Health Care Stocks Moving In Thursday's Intraday Session
↗
October 30, 2025
Via
Benzinga
Why Is Retail Going Gaga Over INTS Stocks Today?
↗
October 30, 2025
The firm announced positive data from a study of INT230-6 in the treatment of metastatic and refractory cancers, with 15 of 64 patients in the trial surviving for more than 21 months.
Via
Stocktwits
Nasdaq Falls Over 1%; Alphabet Posts Upbeat Earnings
↗
October 30, 2025
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
↗
October 30, 2025
Via
Benzinga
Connecticut Biotech Firm Intensity Therapeutics Navigates Critical Reverse Stock Split
October 24, 2025
Shelton, CT – October 24, 2025 – Intensity Therapeutics Inc. (NASDAQ: INTS), a clinical-stage biotechnology company based in Shelton, Connecticut, is proceeding with a pivotal reverse stock split plan,...
Via
MarketMinute
Topics
Artificial Intelligence
12 Health Care Stocks Moving In Friday's Pre-Market Session
↗
October 10, 2025
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
↗
October 01, 2025
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
↗
September 10, 2025
Via
Benzinga
Stay updated with the stocks that are on the move in today's after-hours session.
↗
August 20, 2025
Discover the top movers in Wednesday's after-hours session and stay informed about the post-market dynamics.
Via
Chartmill
Intensity (INTS) Q2 Net Loss Drops 50%
↗
August 07, 2025
Via
The Motley Fool
12 Health Care Stocks Moving In Wednesday's After-Market Session
↗
July 09, 2025
Via
Benzinga
< Previous
1
2
3
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
